Advisory Board
DPPH operates in close coordination with other SPHN/PHRT projects, and involves a high profile Scientific Advisory Board that articulates this coordination and cooperation, with periodic meetings and active information exchange about the project outcomes and directions towards providing an effective security and privacy framework for SPHN seamlessly integrated into the research projects. These are the current members of the DPPH Advisory Board:
Karsten Borgwardt
ETHZ
PI of the SPHN/PHRT-funded project “Personalized Swiss Sepsis Study” (PSSS)
Olivier Michielin
CHUV
Vice-chair of the SPHN Executive Board and PI of the SPHN-funded project “Swiss Personalized Oncology Driver” (SPOD)
Christian Britschgi
Univ. Hospital Zurich
Senior Physician for Medical Oncology and Hematology Co-Director Sarcoma Center – Comprehensive Cancer Center
Sacha Rothschild
Univ. of Basel
Senior Physician Medical Oncology and Head of Clinical Research Medical Oncology at the University Hospital Basel. Member of the SAKK Board.
Christian Lovis
HUG
Member of the SPHN Executive Board and PI of the SPHN-funded project “LOINC for Swiss Laboratories” (L4CHLAB)
Mark Rubin
Univ. of Bern
PI of the SPHN/PHRT-funded project “Swiss Oncology and Cancer Immunology Breakthrough Platform” (SOCIBP)
Torsten Schwede
Univ. of Basel / SIB
Vice President for Research, University of Basel
Didier Trono
EPFL
PI of the PHRT-funded project “TEs as cancer biomarkers and therapeutic targets”